首页> 外国专利> A novel compound, (2R,3R)-4’-O-methyltaxifolin 3-O-β-D-glucopyranoside with postprandial anti-hyperglycemia effect

A novel compound, (2R,3R)-4’-O-methyltaxifolin 3-O-β-D-glucopyranoside with postprandial anti-hyperglycemia effect

机译:一种新型化合物,(2R,3R)-4'-O-甲基停素3-O-β-D-吡喃吡喃糖苷,具有餐后抗高血糖效应

摘要

The present invention relates to a novel compound having the effect of inhibiting postprandial blood glucose rise and a pharmaceutical composition for preventing or treating diabetes comprising the same, and more particularly, to a pharmaceutical composition for preventing or treating diabetes comprising the compound of Formula 3 as an active ingredient it's about The present invention can provide a pharmaceutical composition for preventing or treating diabetes that can be easily and simply prepared and has excellent drug efficacy. In addition, the present invention can provide a pharmaceutical composition for preventing or treating diabetes that can minimize side effects such as weight gain and headache when taken for a long period of time.
机译:本发明涉及一种具有抑制后血糖升高和用于预防或处理包含相同糖尿病的药物组合物的新化合物,更具体地,涉及用于预防或处理包含式3化合物的药物组合物的药物组合物。它是关于本发明的活性成分可以提供用于预防或治疗可以容易且简单地制备的糖尿病和具有优异药物功效的药物组合物。此外,本发明可以提供用于预防或治疗糖尿病的药物组合物,其在长时间服用时可以最小化诸如体重增加和头痛的副作用。

著录项

  • 公开/公告号KR102271683B1

    专利类型

  • 公开/公告日2021-06-30

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR1020190141297

  • 发明设计人 권영인;

    申请日2019-11-06

  • 分类号C07H17/07;A23L33/105;A61K31/7048;A61P3/10;C07H1/08;

  • 国家 KR

  • 入库时间 2022-08-24 19:51:51

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号